Herbalife Stock Surges 18% Following Ronaldo’s $7.5M Investment and Earnings Beat
Herbalife Nutrition Ltd. (HLF) shares skyrocketed 18.32% after football icon Cristiano Ronaldo acquired a 10% stake in its health-tech subsidiary HBL Pro2col Software LLC for $7.5 million. The investment coincided with stronger-than-expected Q4 2025 earnings, where EPS of $0.45 surpassed estimates by $0.02 and revenue reached $1.3 billion against a $1.25 billion forecast.
Ronaldo's MOVE marks his first direct financial involvement with Herbalife after serving as a brand ambassador since 2013. The Pro2col platform leverages user health data to create personalized nutrition plans, positioning Herbalife at the intersection of wellness and technology.
Despite the rally, Wall Street remains cautious with a Moderate Buy rating and $15.60 average price target—20.3% below current levels. The stock's surge reflects both celebrity endorsement power and fundamental performance, with full-year sales growing 1% and Q4 sales up 6.3% year-over-year.